Andrei‐Mircea Catarig
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 27
- Diabetes Management and Research 16
-
- Metabolism, Diabetes, and Cancer 22
- Co-authors
- Ildiko Lingvay (6 shared papers)Matthew Capehorn (2 shared papers)Rory J. McCrimmon (2 shared papers)Desirée Thielke (2 shared papers)Carel W. le Roux (2 shared papers)Nanna L. Lausvig (2 shared papers)Juan P. Frías (2 shared papers)Michel Marre (1 shared paper)
- Journals
- Diabetes Obesity and Metabolism (6 papers)Advances in Therapy (2 papers)Diabetes Therapy (2 papers)Diabetologia (2 papers)Diabetes & Metabolism (1 paper)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Andrei‐Mircea Catarig
29 papers receiving 997 citations
Andrei‐Mircea Catarig's Hit Papers
Peers
Comparison fields: 5 of 57
- Endocrinology, Diabetes and Metabolism 899
- Pharmacology 241
- Molecular Biology 623
- Physiology 115
- Surgery 171
Countries citing papers authored by Andrei‐Mircea Catarig
This map shows the geographic impact of Andrei‐Mircea Catarig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrei‐Mircea Catarig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrei‐Mircea Catarig more than expected).
Fields of papers citing papers by Andrei‐Mircea Catarig
This network shows the impact of papers produced by Andrei‐Mircea Catarig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrei‐Mircea Catarig. The network helps show where Andrei‐Mircea Catarig may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrei‐Mircea Catarig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10) Hit paper breakdown → | 2019 | 283 |
| 2 | 2019 | 208 | |
| 3 | 2020 | 98 | |
| 4 | 2021 | 49 | |
| 5 | 2021 | 36 | |
| 6 | 2021 | 34 | |
| 7 | 2022 | 33 | |
| 8 | 2021 | 31 | |
| 9 | Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2025 | 25 |
| 10 | 2023 | 24 | |
| 11 | 2023 | 21 | |
| 12 | 2022 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2021 | 17 | |
| 16 | 2023 | 17 | |
| 17 | 2023 | 16 | |
| 18 | 2020 | 13 | |
| 19 | 2024 | 12 | |
| 20 | 2024 | 10 |
About Andrei‐Mircea Catarig
Andrei‐Mircea Catarig is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Family Practice, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (27 papers), Metabolism, Diabetes, and Cancer (22 papers), Diabetes Management and Research (16 papers), Pancreatic function and diabetes (4 papers), Peripheral Artery Disease Management (3 papers), Gastric Cancer Management and Outcomes (3 papers), Medication Adherence and Compliance (2 papers) and Coronary Interventions and Diagnostics (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (899 citations), Pharmacology (241 citations), Molecular Biology (623 citations), Physiology (115 citations) and Surgery (171 citations). Andrei‐Mircea Catarig has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Ildiko Lingvay, Matthew Capehorn, Rory J. McCrimmon, Desirée Thielke, Carel W. le Roux, Nanna L. Lausvig, Juan P. Frías, Michel Marre, Bruno Vergès and Andrej Janež. Their work appears in journals such as Diabetes Obesity and Metabolism, Advances in Therapy, Diabetes Therapy, Diabetologia and Diabetes & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.